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The Journal of Immunology
Highly Dynamic Transcriptional Signature of Distinct
Macrophage Subsets during Sterile Inflammation, Resolution,
and Tissue Repair
Tamas Varga,*,1 Re´mi Mounier,†,‡,x,1 Attila Horvath,* Sylvain Cuvellier,{,‖,#
Florent Dumont,{,‖,# Szilard Poliska,*,** Hamida Ardjoune,{,‖,# Gae¨tan Juban,†,‡,x
Laszlo Nagy,*,††,‡‡,2 and Be´ne´dicte Chazaud†,‡,x,{,2
Macrophage gene expression determines phagocyte responses and effector functions. Macrophage plasticity has been mainly
addressed in in vitro models that do not account for the environmental complexity observed in vivo. In this study, we show that
microarray gene expression profiling revealed a highly dynamic landscape of transcriptomic changes of Ly6CposCX3CR1lo and
Ly6CnegCX3CR1hi macrophage populations during skeletal muscle regeneration after a sterile damage. Systematic gene expres-
sion analysis revealed that the time elapsed, much more than Ly6C status, was correlated with the largest differential gene
expression, indicating that the time course of inflammation was the predominant driving force of macrophage gene expression.
Moreover, Ly6Cpos/Ly6Cneg subsets could not have been aligned to canonical M1/M2 profiles. Instead, a combination of analyses
suggested the existence of four main features of muscle-derived macrophages specifying important steps of regeneration: 1)
infiltrating Ly6Cpos macrophages expressed acute-phase proteins and exhibited an inflammatory profile independent of IFN-g,
making them damage-associated macrophages; 2) metabolic changes of macrophages, characterized by a decreased glycolysis and
an increased tricarboxylic acid cycle/oxidative pathway, preceded the switch to and sustained their anti-inflammatory profile; 3)
Ly6Cneg macrophages, originating from skewed Ly6Cpos cells, actively proliferated; and 4) later on, restorative Ly6Cneg macro-
phages were characterized by a novel profile, indicative of secretion of molecules involved in intercellular communications,
notably matrix-related molecules. These results show the highly dynamic nature of the macrophage response at the molecular
level after an acute tissue injury and subsequent repair, and associate a specific signature of macrophages to predictive specialized
functions of macrophages at each step of tissue injury/repair. The Journal of Immunology, 2016, 196: 4771–4782.
S
terile inflammation is the response to tissue damage. After
mounting inflammation to remove tissue debris, resolution
of inflammation takes place to allow tissue repair. Mac-
rophages are major players in these processes because they are
involved in both mounting and resolution of inflammation, as well
as in subsequent tissue repair. These multiple roles are possible due
to their high versatility and plasticity (1). Macrophage plasticity
has been mainly explored in vitro, where defined conditions of
stimulation led to the definition of activation states. Classically
activated macrophages (M1) were originally elicited by IFN-g (then
later on by LPS) and secrete proinflammatory compounds (IL-12,
IL-1b, TNF-a, reactive oxygen species, and so on). Alternative
activation state was first described upon IL-4 exposure. M2 macro-
phages notably express YM1, arginase 1, CCL24, and CCL17.
However, a series of stimuli (glucocorticoids, TGF-b, IL-10, etc.)
induce M2-like phenotypes, which overlap with each other in the
expression of some genes and functions (2). Moreover, it has been
recently shown that even in a controlled in vitro context, a variety
of stimuli induce some intermediate phenotypes between the
originally described M1 and M2 profiles (3).
In vivo analyses of macrophages used transgenic mice strains
able to trace macrophage subsets, which fates and phenotypes
depend on the tissue and the immune context (4–7). Tissue damage
induces the infiltration of CCR2posCX3CR1loLy6Cpos monocytes that
express proinflammatory markers. In all tissues studied so far, reso-
lution of inflammation is associated with a shift of the inflammatory
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status of macrophages that become CCR2negCX3CR1hiLy6Cneg
(4, 5, 7). The latter sustain dampening of inflammation and tissue
remodeling (1). Based on the analysis of a series of markers, the
CCR2posCX3CR1loLy6Cpos/CCR2negCX3CR1hiLy6Cneg macro-
phage subsets were proposed to mirror the M1/M2 in vitro para-
digm. However, aligning the macrophage phenotypes observed
in vivo with those described in vitro has proved difficult because
of the overlapping of several markers in the in vivo populations
(8). Recent studies, based on high-throughput technologies, have
defined phenotypes of in vivo macrophages, but these studies have
been mainly carried out in resting tissues. They defined a core
signature of macrophages, helping the identification of new pan-
macrophage markers, such as CD64 and merTK (9). In contrast,
genomic analyses evidenced that tissue-resident macrophages iso-
lated from a variety of tissues exhibit specific enhancer/transcriptional
signature according to the tissue where they reside (10, 11). As a
whole, very little information is available about the dynamics of
the molecular signature of macrophages during acute inflamma-
tion and subsequent tissue repair in vivo.
We provide in this article a comprehensive analysis of the dyna-
mics of themolecular signature of macrophages from themounting of
the immune response to the resolution of inflammation and tissue
repair. For this purpose, the model of postinjury skeletal muscle
regeneration, which follows a reproducible kinetics of macrophage
subset transition, was used in the CX3CR1GFP/+ mouse strain,
which allows to trace macrophages (4–7, 12). Macrophage subsets
were isolated at various time points of muscle regeneration and
their transcriptomic profile was analyzed by microarray, defining
new molecular pathways characterizing in vivo dynamics of mac-
rophage populations during tissue repair.
Materials and Methods
Mice
CX3CR1GFP/+ mice were bred and used according to French legislation.
Experiments were conducted at 8–10 wk of age. Muscle injury was caused
by i.m. injection of cardiotoxin (CTX) in the tibialis anterior muscle, as
previously described (13). Muscles were harvested 1, 2, 4, and 8 d post-
injury. In some experiments, CTX was coinjected with LPS (50 mg/ml
final). Muscle fascia was removed; then muscles were either dissociated
or frozen in nitrogen-chilled isopentane and kept at 280˚C until use.
Histology
Cryosections were prepared for H&E staining and immunolabeling. Immu-
nolabeling used anti-F4/80 (ab6640, ab74383; Abcam), Lcn2 (BAF1857;
Biotechne), saa3 (provided by P.E. Scherer, Dallas, TX), and haptoglobin
(ab35835; Abcam) Abs. Secondary Abs were coupled to FITC, Cy3, or Cy5
(Jackson Immunoresearch). HE‐stained muscle sections were recorded with
a Nikon E800 microscope at 203magnification connected to a QIMAGING
camera. Fluorescent immunolabeling was recorded with a Zeiss Axio Ob-
server Z1 microscope connected to a Coolsnap camera at 203magnification.
Isolation of macrophages from skeletal muscle was performed as described
earlier (13) after sorting of CD45pos cells and labeling with allophycocyanin-
conjugated anti-Ly6C/G Abs (eBioscience), using a FACSAria III cell sorter
(BD Biosciences). Cells were immediately centrifuged and RNA was
extracted with the TRIzol/chloroform procedure. Validation of cell identity
was assessed by flow cytometry using anti-CD64, anti-F4/80, and anti-
CD103 (eBioscience) Abs.
Real-time quantitative RT-PCR
RNA was extracted from isolated CD45pos cells with TRIzol/ethanol precipi-
tation. Transcript quantification was performed by real-time quantitative RT-
PCR using SYBR green assays (Ifitm6 and Serpinb2) or PrimeTime assays
from IDT (Il1f9, Saa3, and S100a9). Results were analyzed with the standard
delta cycle threshold method and were normalized to the expression of ActB.
Microarray processing
RNA integrity was checked on Agilent Bioanalyzer 2100, RNA samples
with .9.0 RNA integrity number value were used in the downstream
experiments. NanoDrop ND-1000 was used to determine RNA concen-
tration. Global expression data were obtained using Affymetrix GeneChip
Mouse Gene 1.0 ST arrays. Ambion WT Expression Kit (Life Technolo-
gies) and GeneChip WT Terminal Labeling and Control Kit (Affymetrix)
were used for generating biotin-labeled sense strand cDNA. The bio-
tinylated sense strand cDNA samples were hybridized at 45˚C for 16 h;
then standard washing protocol was performed using Affymetrix Gene-
Chip Fluidics Station 450, and the arrays were scanned on GeneChip
Scanner 7G (Affymetrix). The microarray data are publicly available (data
access: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE71152).
Expression data processing and analysis
Data quality control and analysis were carried out following the recom-
mendations put forward on the ImmGenWeb site (http://www.immgen.org/
Protocols/ImmGen%20QC%20Documentation_ALL-DataGeneration_0612.
pdf). Data were loaded into the Genespring GX software, and robust multi-
array average summarization was carried out. Next, a set of filtering steps
was applied to the data set. In brief, data distribution curve was generated
and the lowest 5% of the entities with detectable signals were filtered out
as not expressed. Duplicate entities, not/poorly annotated transcripts and
transcripts reporting inconsistent expression values were also discarded.
Further analysis was carried out on the filtered data set. Data were analyzed
either based on the RAW expression values or after a “per gene” normali-
zation (individual gene expression data normalized to the median of the
gene). Further analysis of gene expression and comparisons were made
either within Genespring GX or using the R software package. Two-way
ANOVA tests were performed in R using functions aov and Tukey HSD of
package MASS. Heat maps were drawn with package pheatmap. Statisti-
cally significant difference was considered as p , 0.05.
Clusterization of genes according to the time
Data were robust multi-array average normalized with R/Bioconductor.
Data were first controlled and analyzed in an unsupervised way by prin-
cipal component analysis (PCA), and a one-way ANOVA was applied to
extract DEGs using PartekGS software. Genes were selected on the global
p , 0.01. A cluster analysis was then applied on selection by hierarchical
clustering (Pearson for similarity and average for clustering) to find cor-
relate genes. Enrichment analyses were carried out through the use of IPA
and Pathway Studio software.
Comparison with previously described modules
Gene set enrichment analysis (GSEA) was performed as described pre-
viously (14) using the KEGG pathway database (http://www.genome.jp/
kegg/pathway.html) as in Jha et al. (15) and for 49 gene sets associated
with macrophage activation as in Xue et al. (3).
Gene ontology analysis
Lists of genes in the clusters were analyzed using DAVID tool (http://david.
abcc.ncifcrf.gov/home.jsp) using at least 10 occurrences to create a gene
ontology (GO). GOs with p values ,0.05 were then entered together with
their p value in REViGO tool (http://revigo.irb.hr/), and results were pre-
sented according to their log10 p value.
Results
Experimental setup
Injection of CTX in tibialis anterior muscle of CX3CR1GFP/+ mouse
triggers damage of the whole muscle, a massive infiltration of
Ly6CposCX3CR1lo monocytes/macrophages, followed by a sequence
of well-characterized events triggering muscle regeneration (12,
16). At day 1 after injury, myofibers were necrotic, whereas neu-
trophils and circulating CCR2posCX3CR1loLy6Cpos monocytes en-
ter into the damaged muscle to create Ly6CposCX3CR1lo macrophages
(Fig. 1). They represent the majority of macrophages at this time
point (∼1800 macrophages/mg muscle [13]). At day 2, macro-
phages phagocyted the dead myofibers and skewing from Ly6Cpos
CX3CR1lo (hereafter Ly6Cpos) to Ly6CnegCX3CR1hi (hereafter
Ly6Cneg) macrophages had already started (17, 18) (Fig. 1). They
represent ∼5000 and 5500 macrophages/mg muscle, respectively
(13). Day 4 after injury, the regeneration process was visible with
the appearance of the new regenerating myofibers surrounded by
numerous macrophages, which were mainly Ly6Cneg at this stage
(∼5100 versus 750 macrophages/mg muscle [13]). At day 8, muscle
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had almost recovered its original appearance, with neofibers char-
acterized by the central location of their nuclei and the progressive
disappearance of macrophages (600 Ly6Cneg macrophages/mg
muscle [13]). Macrophages were sorted according to their Ly6C
and CX3CR1-GFP expression. Macrophage identity of the isolated
CD45posCX3CR1pos muscle cells was confirmed by the almost
complete overlap of CX3CR1 labeling with two macrophage
markers, F4/80 and CD64, and by the absence of overlap of CX3CR1
labeling with the DC markers CD103 (Fig. 1). Pure populations
(.98%) were obtained (Fig. 1) and global gene expression analysis
FIGURE 1. Histological characterization of muscle regeneration and macrophage sorting strategy. Tibialis anterior muscles from CX3CR1GFP/+
mice were injected with CTX and were recovered at various days after injury. (A) Top row presents H&E staining of muscle sections. Bottom row
presents cell sorting of CD45pos cells isolated from regenerating muscle according to their Ly6C/G and GFP (CX3CR1) expression. Blue dots label
Ly6C/GposCX3CR1neg neutrophils. Pink dots label Ly6CposCX3CR1lo macrophages. Green dots label Ly6CnegCX3CR1hi macrophages. Dot plots on
the left give examples of the purity of sorted macrophage populations. Scale bar, 30 mm. (B) CD45pos cells were labeled for the detection of Ly6C and
for canonical macrophage (F4/80 and CD64) or DC (CD103) markers to validate the macrophagic identity of CX3CR1-(GFP)pos cells. Gating is made
on GFPpos cells.
The Journal of Immunology 4773
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was performed. Because normal skeletal muscle parenchyma con-
tains only few macrophages (12, 19), this state was not evaluated.
Notably, with very few amounts of Ly6Cpos cells being recovered at
day 8, only one point (and not triplicate) was analyzed, to avoid
unethical sacrifice of numerous mice.
Muscle macrophages among other macrophage subtypes
PCA analysis of muscle macrophages versus monocytes, mac-
rophages, and DCs sorted from various tissues and identified
by the ImmGen Consortium (9, 20) revealed that muscle
macrophages formed a distinguishable group (Supplemental
Fig. 1A). Because a technical batch effect resulting in a simi-
lar pattern cannot be excluded, the batch removal utility of the
Iimma R package (21) was used. The analysis showed that
batch effects played a detectable but minor role in the PCA
analysis, and that the two-dimensional PCA distribution of
muscle macrophages was not altered (Supplemental Fig. 1B).
We therefore suggest that the specific clustering of muscle
macrophages is mostly due to their origin from a regenerating
and not a resting tissue. Expression of Ly6C and Cx3cr1 genes
reported the expected patterns in the sorted populations and
validated the sorting strategy (Fig. 2A). ImmGen proposed a
list of genes that are the most specific to macrophages and
classical DCs (9, 20), which was compared with muscle-derived
macrophages (Supplemental Fig. 2A). Three genes (Slamf7, Ass1,
and Gpr132) showed a DC-like expression pattern in all muscle-
derived macrophages. Eighteen of the 24 classical DC genes were
either not (Rab30, Hmgn3, Gpr82, etc.) or were weakly (kit,
amica1, ap1s3, pvrl1, etc.) expressed by muscle macrophages.
The three remaining genes (CCR7, P2Ry10, and Adam19) were up-
regulated in Ly6Cneg macrophages notably at late time points.
Conversely, muscle-derived macrophages clearly expressed a
core macrophage signature and clustered with macrophages sorted
from other origins, and apart from DCs (Supplemental Fig. 2B).
Only a few genes (Pecr, Tmem195, and Pla2g15) were not or were
very weakly expressed.
Unique molecular signature of muscle macrophage subsets
PCA showed that macrophage populations segregated by day, more
than by their LyC6pos/neg status (Fig. 2B). Day 1–2 macrophages
clustered together, whereas day 4–8 macrophages clustered to-
gether apart, corresponding to the proinflammatory phase (days
1–2) and the resolving/regenerative phase (days 4–8) of muscle
regeneration, respectively. Scatterplots of gene expression changes
between macrophage subsets showed a correlation coefficient
r value of 0.222 at day 2, indicating that the most differential
transcriptional changes occurred at day 2, which corresponds to
the beginning of skewing of macrophages from Ly6Cpos to
Ly6Cneg phenotype (13, 22) (r values of 0.696, 0.756, and 0.499,
for days 1, 4, and 8, respectively) (Fig. 2C). Further analysis of
differential gene expression involved two-way ANOVA analysis,
followed by Tukey post hoc tests (p , 0.05) (Supplemental
Table 1). Fig. 2D shows a scheme of the comparisons made, with
the number of genes showing significant differences between any
two conditions. In vertical comparisons, Ly6Cpos were compared
with Ly6Cneg macrophages for each time point. Confirming the
earlier analyses, the highest number of differentially expressed
genes was observed at day 2 of regeneration. In horizontal com-
parisons, each macrophage subset was compared with its closest
neighboring time points to analyze variation of gene expression
longitudinally along the regeneration process. The numbers of
genes differentially expressed in horizontal comparisons were
higher than that in vertical comparisons, confirming the PCA anal-
yses. Thus, although Ly6Cpos and Ly6Cneg macrophages were
different, both underwent larger transcriptomic changes during the
time course of muscle regeneration, and particularly between days
2 and 4 (Fig. 2D).
FIGURE 2. Global molecular signature of muscle macrophage subsets.
(A) Expression of cell-surface markers used for the cell sorting strategy by
Ly6Cneg and Ly6Cpos macrophages. (B) PCA on all muscle-derived mac-
rophage subsets during regeneration. (C) Comparison of the gene expression
pattern of Ly6Cneg and Ly6Cpos macrophages at different days. Scatterplots
show normalized expression of each transcript of the curated entity list
(positive with red; negative with blue; unchanged with gray) in Ly6Cneg or
Ly6Cpos cells. Solid lines represent one-dimensional regression model with
95% CI. (D) Schematic of macrophage subset comparisons with two-way
ANOVA analysis (see Supplemental Table 1). Numbers represent upreg-
ulated and downregulated genes between the compared conditions. Arrows
point toward inductions.
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Comparative analysis of Ly6Cpos and Ly6Cneg macrophage
subsets
Previous studies showed that Ly6Cpos macrophages express higher
levels of TNF-a and IL-1b and lower levels of TGF-b and IL-10
than Ly6Cneg macrophages (12, 16, 23). Therefore, they were con-
sidered as proinflammatory and anti-inflammatory macrophages,
respectively. However, the analysis of a series of markers showed
that, in general, Ly6Cpos and Ly6Cneg macrophages did not exhibit
high differential expression levels of proinflammatory (M1) and
anti-inflammatory (M2) markers (Fig. 3A, 3B). The difference in
expression was modest and reached significance only for Tlr4,
IL1rap, IL15, and IL18 genes of the 23 investigated proin-
flammatory markers (Fig. 3A) and for 6 of the 40 anti-inflammatory
genes analyzed (Irf4, Ccl17, Ccl22, Ccl12, Clec10a, and Socs2)
(Fig. 3B) at day 1. These results show that Ly6Cpos and Ly6Cneg
macrophages in regenerating muscle cannot be defined as canonical
M1 or M2 macrophages. To refine muscle-derived macrophage
subset phenotypes, we performed GSEA enrichment against the
49 modules of genes defined by Xue et al. (3), in which various
combinations of these modules characterize 29 conditions of in
vitro activation of human macrophages (Supplemental Table 2).
Among all comparisons, only genes upregulated in Ly6Cneg mac-
rophages at day 4 of regeneration were associated with 26 modules.
The best representative combinations (Supplemental Table 2) were
treatments with fatty acids (oleic, stearic, and lauric acid) and with
TNF-a+Pam3CysSerLys4+PGE2, all of which triggered opposite
activation status along the IFN-g/IL-4 activation axis (3). These
results indicate that, in vivo, macrophages display highly different
inflammatory profiles than those previously described in vitro and
from the M1/M2 nomenclature.
The expression pattern of a series of molecules secreted by
macrophages and involved in myogenesis (insulin-like growth
factors, urokinase plasminogen activator, platelet-derived growth
factor a, hepatocyte growth factor, bone morphogenetic protein 2
[24–29]) was increased with time of regeneration, and particularly
in Ly6Cneg macrophages (Fig. 3C). This shows good overlap with
anticipated expression patterns of regulators of muscle regenera-
tion. This indicated that an unbiased analysis of gene expression
patterns might report yet unidentified molecular mechanisms
during both acute and resolution phases of inflammation.
Comparison of Ly6Cpos and Ly6Cneg macrophage subsets
during muscle regeneration
Vertical comparison between Ly6Cpos and Ly6Cneg macrophages at
day 1 showed that the list of upregulated genes in Ly6Cpos macro-
phages (Fig. 2D, Supplemental Table 1) was enriched for GO terms
associated with innate immune response and cell locomotion
(Supplemental Table 3), in accordance with a role in the mounting
of the inflammatory response. Strikingly, 8 of 10 of the top-ranking
genes were related to inflammation (Supplemental Table 1). Thus,
the “find similar entity” algorithm of the Genespring software (with
similarity setting 0.5–1) was used to find genes that were regulated
similarly as Il1f9, the top-ranked inflammatory gene at day 1 of
muscle regeneration. Altogether, 38 genes were identified, among
which 17 genes are linked to inflammation (Fig. 4A, underlined in
red) and therefore constitute the best molecular signature of
Ly6Cpos macrophages after a sterile muscle damage. This panel of
Ly6Cpos inflammatory genes showed very good overlap with the
genes identified by the GO/REVIGO approach, including alarmins
(S100a8 and S100a9) and several acute-phase proteins (Lcn2,
Lrg1, Hp, and Saa3). The biological relevance of this expression
was confirmed by the detection of haptoglobin, lipocalin-2, and
Saa3 proteins in macrophages (F4/80pos) in early regenerating
muscle (Fig. 4B).
Classical activation has been originally linked to the IFN-g–
STAT1 signaling pathway (2, 30). We showed that the IFN-g–
responsive gene, Ifitm6, as well as Saa3, Il1f9, Serpinb2, and
S100a9, were not differentially expressed in wild-type (WT) versus
STAT1 knock-out CD45pos cells sorted from early regenerating
muscle (Fig. 4C), indicating that the inflammatory profile of
Ly6Cpos macrophages was not driven by IFN-g. Nevertheless, the
expression of these genes relied on a proinflammatory profile
because the coinjection of CTX with LPS strongly induced their
expression (Fig. 4C).
From day 2, vertical comparisons reflected the proliferative nature
of Ly6Cneg muscle macrophages as they showed a high enrichment
for cell cycle and cell division GOs, particularly 2 and 4 d after
injury (Supplemental Table 3), confirmed by the definition of a
cell cycling molecular signature of the Ly6Cneg macrophage subset
(Fig. 3D), that was previously evidenced at the cell level by ex-
periments showing that only Ly6Cneg macrophagic cells were ca-
pable of proliferation (12).
Dynamics of Ly6Cpos macrophages during the course of muscle
regeneration
Ly6Cpos macrophages are the most numerous during the first steps
of regeneration. From day 2, they start to switch their phenotype
into Ly6Cneg cells (13) whose number gradually increases. Hori-
zontal comparisons showed no specific GO function enrichment
between days 1 and 2 of regeneration (Fig. 2D). The most im-
portant changes were observed between days 2 and 4 of regen-
eration when the cells showed marked differential expression of
genes related to inflammation and metabolism (Supplemental
Table 4). Among the upregulated genes (see top/bottom genes in
Supplemental Table 1) were found a series of molecules involved
in the interactions with adaptive immunity (Cd209d, Cd8b1, Cd7,
Ifng, Cd4, Cd3e, Ciita, Cd8a, Gbp4, P2ry14, Cd28, Cxcl9), whereas
both proinflammatory and anti-inflammatory secreted effectors
were downregulated (Ppbp, Cxcl3, Il6, F10, Cxcl1, Il1f9, Il10,
Itga1, Clec4d, Olr1, Sphk1, Ednrb). A strong decrease of expression
of genes involved in transcription, translation, and lipid metabolism
was observed (Arg1, Agpat9, B3gnt5, Ero1l, Sgms2, Car5b, Avpi1,
Gyk, Ell2, Car6, Agpat4, Gpd2, Odc1, Idi1, Padi4, Eif4e, Nop58,
Mboat1, Eef1e1). A complementary tool to analyze gene expression
with time was to cluster the genes according to their kinetics of
expression. Genes differentially expressed by Ly6Cpos macrophages
gathered in only two main clusters that presented radical changes in
gene expression profile between days 2 and 4 (Fig. 5). Accordingly,
the GO enrichments observed in clusters 1 and 2 matched with
those observed for downregulated and upregulated genes between
days 2 and 4 depicted earlier. Although much less numerous from
day 4, Ly6Cpos macrophages exhibited gene expression variations in
some part similar to those of Ly6Cneg cells (see later) during the late
steps of regeneration (Supplemental Table 4), indicating that the
environment largely controls gene expression of this cell subset
from day 4. Notably, because a single sample was available for
Ly6Cpos cells at day 8, some variations between days 4 and 8, such
as upregulation observed in some genes of cluster 1 (and exem-
plified in Fig. 4A), were not taken into account for this scarce
population at this time point.
Dynamics of Ly6Cneg macrophages during the course of muscle
regeneration
Horizontal analysis showed that Ly6Cneg cells upregulated genes,
first associated with the preparation of proliferation and then with
cell division, until day 4 (Supplemental Table 4), confirming the
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earlier vertical analysis. GO terms related to response to wounding
and immune response were variably regulated in Ly6Cneg mac-
rophages but clearly showed a downregulation of genes associated
with chemotaxis and cell motility in the early regenerating phases
(see top/bottom genes in Supplemental Table 1) (e.g., Fpr1, Cxcl3,
Ccl24, Itga1, Il6, Arg1, Clec4n, Ccl22, Pecam1, Itgal, Selp). At
later stages, GO categories including intracellular signal trans-
duction associated with immune response and cell communication
(regulation of cytokine production; Supplemental Table 4) were
upregulated (e.g., Itk, Ralgds, Adora2b, Arl5b, Map2k3, Fosl2,
FIGURE 3. Analysis of inflammatory markers in Ly6Cpos versus Ly6Cneg macrophage subsets. Expression pattern of proinflammatory (A) and anti-
inflammatory (B) markers of genes involved in myogenesis (C) and genes associated with cell cycle (D) by regenerating Ly6Cpos and Ly6Cneg muscle-
derived macrophages.
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Rab20, Gem, Dusp16, Rapgef2, and Rcan1 for signal transduction
and Il6, vcam1, Il10, Cd81, Bmp2, Fasl, Ccl22, Pdgfb, Ctla4, Il1a,
Malt1, and Tigit for immune response) (Supplemental Table 1).
Finally, genes associated with the metabolism of ribosomes/RNA,
glucose, and macromolecules were downregulated at the late steps
of regeneration, indicating a metabolic shift in macrophage sub-
sets during regeneration (Supplemental Table 4). Some of the most
downregulated genes were related to the redox status (Arg1, Odc1,
FIGURE 4. Genes highly expressed by infiltrating Ly6Cpos macrophages during early steps of muscle regeneration. (A) Heat map of genes upregulated
by Ly6Cpos as compared with Ly6Cneg at day 1 after injury, including a series of genes associated with inflammation (underlined in red). (B) Immuno-
histofluorescence showing the expression of acute-phase proteins (green) by F4/80pos macrophages (red) in skeletal muscle day 2 after injury. Arrows show
examples of double-labeled cells. Asterisks show necrotic myofibers trapping some Abs nonspecifically. Scale bar, 50 mm. (C) Real-time quantitative RT-
PCR of genes highly expressed in Ly6Cpos macrophages at day 1 of regeneration in CD45pos cells of WT and STAT1 knock-out mice at days 1 and 2 of
muscle regeneration after CTX injection. In some experiments, LPS has been injected together with CTX in WT animals. Results are mean6 SEM of three
independent experiments. **p , 0.01, ***p , 0.001.
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Car6, Mdm2, Srxn1, Ero1l, Txnrd1, Adssl1, Sod2, Rars, Gclc,
Gpd2) (Supplemental Table 1).
Overall, the differentially regulated genes in Ly6Cneg cells clus-
tered into six groups according to their kinetics of expression (Fig. 5).
Clusters 4 and 5 contained genes highly expressed at days 1–2 of
regeneration and were enriched for various GOs including RNA
metabolism, transcription, translation, preparation of the cell to en-
ergy expenditure, and intracellular transport (Fig. 6, Supplemental
Table 5). Genes showing a progressive (cluster 1) or strong (cluster
2) upregulation at day 4 showed enrichment in GOs associated with
DNA packaging, macromolecule synthesis and assembly, and cell
cycle (Fig. 6, Supplemental Table 5). Cluster 3 encompassed genes
showing an upregulation with time, particularly between days 4 and
8, and was enriched for wound healing, regulation of cell activation,
cytokine production, and cell communication GOs (Fig. 6, Supplemen-
tal Table 5). Cluster 6 gathered genes whose expression decreased
until day 4 and strongly increased between days 4 and 8. Cluster 6
was enriched for GO terms associated with wound healing and cell
communication including regulation of cell differentiation, response
to signaling, and tissue remodeling, among which are secreted
molecules (Fig. 6, Supplemental Table 5).
Metabolic shift of macrophages during skeletal muscle
regeneration
The earlier horizontal analysis of macrophage profile suggested
metabolic changes during muscle regeneration. Detailed metabolic
regulation has been recently investigated in in vitro–activated
macrophages and showed that M2(IL-4) macrophage profile was
associated with glutamine metabolism, involved in activation of
tricarboxylic acid (TCA) cycle and oxidative phosphorylation
(15). Most of the genes (16/22) identified as being dependent on
glutamine in Jha et al.’s study (15) were upregulated during the
late steps of muscle regeneration (Fig. 7A), suggesting that ox-
idative metabolism is associated with Ly6Cneg macrophage func-
tions that are more numerous at this time. Moreover, GSEA
analysis against the KEGG database was performed for horizontal
comparisons as in Jha et al.’s study. In both macrophage subsets
(Supplemental Table 6), pathways that were upregulated between
days 1 and 2 of regeneration were linked to oxidative metabolism
(KEGG citrate cycle TCA cycle, KEGG oxidative phosphoryla-
tion, KEGG fatty acid metabolism, KEGG pyruvate metabolism,
etc.). Most of these pathways were then downregulated from day 4
of muscle regeneration (Supplemental Table 6). These results in-
dicate important metabolic changes in macrophages, with an up-
regulation of oxidative metabolism preceding the change of their
inflammatory status.
Secretory profile of Ly6Cneg macrophages during the late steps
of muscle regeneration
GO cell component enrichment of the 10% most differentially
expressed genes revealed that clusters 3 and 6, encoding for genes
upregulated at the end of the regeneration process, were enriched
for extracellular/secreted products (Fig. 6). Among the most dif-
ferentially regulated genes, several genes encoding for extracel-
lular matrix (ECM) components and ECM remodeling proteins
were observed. Bgn and Postn, encoding for two ECM proteins,
were among the top-ranked upregulated genes in Ly6Cneg mac-
rophages between days 2 and 4. Scrutinizing the entire list led to
the identification of a set of ECM genes highly expressed by
Ly6Cneg macrophages during the late phases of muscle regener-
ation (Fig. 7B). This indicates that macrophages are direct con-
tributors of ECM reorganization during the healing phase of tissue
repair.
Discussion
Macrophage plasticity is a major paradigm in innate immunology.
In vitro experimental systems lack both the complex milieu present
in vivo and the dynamic aspects of macrophage phenotype shifts.
We have addressed this issue by taking advantage of a highly dy-
namic sterile inflammatory model, CTX-induced muscle regenera-
tion, inwhich acute inflammation is rapidly followed by the resolution
of inflammation and ensuing regeneration process. In this model,
we have assessed the transcriptomes of macrophage populations,
FIGURE 5. Clustering of genes according to their kinetics of ex-
pression. (A) Clustering of genes in Ly6Cpos macrophages revealed two
main clusters. (B) Clustering of genes in Ly6Cneg macrophages revealed
six clusters.
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which revealed unexpected highly dynamic changes of gene ex-
pression during acute inflammation and subsequent tissue repair,
confirming the highly versatile nature of these cells.
We show that macrophages from regenerating muscle were dis-
tinct from resting macrophages in other tissues, while they exhibited
a pronounced macrophage-like core expression signature, particu-
FIGURE 6. GO analysis of clusters of genes expressed by Ly6Cneg macrophages. Clusters of genes showing the highest expression at days 2 (clusters 4
and 5), 4 (clusters 1 and 2), and 8 (clusters 6 and 3) of muscle regeneration were analyzed in DAVID for GO-biological processes and clustered with
REViGO tool. Main GO clusters are represented in pie charts according to their significance. Details are presented in Supplemental Table 5. Histograms
below the pie chart present, for each cluster, GO-Cell component enrichment. White bars represent GOs associated with genes coding for intracellular
proteins; gray bars represent GOs associated with genes coding for membrane proteins; black bars represent GOs associated with genes coding for ex-
tracellular proteins.
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larly at late time points of regeneration. They also expressed at these
late stages some DC markers, especially in the Ly6Cneg subset.
Expression of DC markers by monocyte-derived macrophages has
already been shown (5, 8), and some DC properties have been
identified for macrophages in late regenerating muscle (31).
Analysis of gene expression revealed that the elapsed time, much
more than Ly6C status, showed the highest differential gene ex-
pression in macrophages during muscle regeneration. Thus, the
time course of inflammation is the predominant organizing force in
gene expression by macrophages, with an important time point at
days 2–4 postinjury, which corresponds to the full skewing from
Ly6Cpos to Ly6Cneg status (13, 16) and the starting of resolution of
inflammation. This result is a clear departure from the widely held
assumption that the Ly6Cpos/neg status is the predominant defining
feature of these macrophages with strong predictive power for
their molecular signature/functions. A highly related issue is the
polarization status of the Ly6Cpos/neg subsets, which have been
assumed to correspond, as in other tissues, to M1 and M2 macro-
phages, respectively (13, 16, 23). We show that the damage-asso-
ciated Ly6Cpos macrophages exhibited a specific inflammatory
profile, independent of STAT1, which only partially overlapped
with the broad M1 gene expression pattern and displayed a unique
inflammatory signature during the early response to muscle injury
(days 1–2), likely reporting sterile inflammation (see later). Simi-
larly, Ly6Cneg macrophages were unsuccessfully linked to canonical
M2(IL-4) macrophage. Although they preferentially expressed anti-
inflammatory markers, their expression profile did not match with
any of the in vitro activation status tested so far (3). Only partial
overlap was observed with macrophages stimulated with fatty
acids (3). These results indicate that in vivo macrophages cannot
be restricted to the M1/M2 nomenclature during tissue injury/repair.
Instead, we evidence four specific features that account for the high
dynamic changes in gene expression observed in macrophages
during muscle regeneration.
The first feature is early expression of acute-phase proteins by
Ly6Cpos macrophages. Ly6Cpos macrophages entering the injured
FIGURE 7. Metabolism- and ECM-related genes highly expressed in Ly6Cneg macrophages. (A) Heat maps of genes regulated by the presence of
glutamine and associated with oxidative metabolism as described by Jha et al. (15) in Ly6Cpos and Ly6Cneg macrophages during muscle regeneration. (B)
Heat maps of genes associated with ECM and ECM regulation, in Ly6Cpos and Ly6Cneg macrophages during muscle regeneration.
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muscle highly expressed genes involved in inflammation, includ-
ing acute-phase proteins, such as SAA3, S100A8/9, Lipocalin-2,
and Haptoglobin (32). Both pathogen-associated and damage-
associated molecular pattern molecules induce macrophage ex-
pression of S100A8 and S100A9 (33), which dimerize to form
calprotectin, which, in turn, triggers SAA3 expression (34) by
macrophages (35–37). Interestingly, macrophage-derived calpro-
tectin is an early contributor of skeletal muscle myositis, which is
characterized by a huge inflammatory infiltrate (38) and is also
upregulated after exercise (39), suggesting that these macrophage-
derived proteins are crucial for launching the regeneration/remodeling
process in skeletal muscle. Lipocalin-2 and haptoglobin are
involved in the regulation of iron metabolism, by binding small
iron-carrying molecules (siderophores) and hemoglobin (before
internalization by CD163 receptor), respectively. Iron capture
protects against iron-mediated toxicity (40). This is in agreement
with the described iron retention phenotype of M1 macrophages
(41), which also has been described in early regenerating muscle
(42). It has been shown that chelatable iron release from disrupted
muscle tissue represents the major cause for the oxidative stress
that aggravates muscle destruction (43). Thus, high expression of
iron-scavenging molecules by Ly6Cpos macrophages may favor
iron elimination to protect the tissue.
Second, metabolic change of macrophages precedes and sus-
tains the resolution of inflammation. Although metabolism is
foreseen as an important regulator of macrophage function, no-
tably in diseases (44), few studies addressed specific metabolic
pathways linked to specific macrophage inflammatory status. The
shift from M1 to M2 macrophages is associated with a change in
glucose metabolism, with a reshuffling from glycolysis to oxidative
metabolism (13, 45, 46). Accordingly, we observed at the time of
resolution of inflammation (between days 2 and 4) a downregula-
tion of genes associated with glycolysis and glucose metabolism in
both Ly6Cpos and Ly6Cneg macrophages. This was preceded by an
early upregulation, between days 1 and 2, of the pathways associ-
ated with oxidative phosphorylation and TCA cycle, suggesting that
macrophages first started to shift their metabolic profile before
shifting their inflammatory status. Finally, we observed a strong
upregulation of genes involved in glutamine metabolism, associated
with oxidative metabolism, which is characteristic of M2(IL-4)
macrophages in vitro (15), during the late steps of muscle re-
generation (days 4–8). These results suggest that metabolic shift
precedes inflammatory shift in macrophages and that a specific
metabolic signature characterizes recovery macrophages during
the repair phase.
The third feature is proliferation of Ly6Cneg macrophages, which
likely explains the high numbers of Ly6Cneg macrophages present
in the muscle later on (12). Kinetic analysis showed the molecular
foundation that allowed Ly6Cneg macrophages to get prepared for
division at day 1 and to actively divide at days 2–4 of regenera-
tion. Similarly, macrophage proliferation occurs at the time of
resolution of inflammation in peritonitis (47). Moreover, expres-
sion of M-CSF, which is essential to macrophage proliferation
(47), was highly enhanced in macrophages between days 2 and 4
of muscle regeneration (Supplemental Table 1).
The fourth feature is expression of ECM components by Ly6Cneg
macrophages during the healing phase. Ly6Cneg macrophages
expressed mainly secretory proteins at days 4–8 of regeneration,
which are involved in intercellular communication. A specific
enrichment was observed for ECM and ECM-regulating proteins,
including proteoglycans, matricellular proteins, and assembly pro-
teins. Interestingly, most of these molecules are involved in skeletal
muscle regeneration and some of them are expressed by macro-
phages during tissue repair (Supplemental Table 7). These results
suggest that macrophages directly participate in the synthesis and
assembly/organization of ECM constituents.
In conclusion, this study highlights an unexpected dynamic
nature of macrophage subset gene signature during skeletal muscle
regeneration. Early-arriving Ly6CposCX3CR1lo macrophages, which
exhibit damage-associated, highly specialized molecular signature,
sense and report tissue injury by producing acute-phase proteins,
alarmins, and other factors. These macrophages early modify their
cellular metabolism (downregulation of glycolysis pathway, up-
regulation of oxidative pathway), and later on their inflammatory
phenotype, to become anti-inflammatory Ly6CnegCX3CR1hi mac-
rophages. These latter actively divide while participating in a
regeneration/healing process through the secretion of molecules
involved in intercellular communications, notably ECM-related
molecules, which are crucial for the recovery of muscle integrity.
Ly6CnegCX3CR1hi macrophages fulfill the designation of restor-
ative macrophages given their ability to produce proregenerative
factors (e.g., insulin-like growth factor-1 [29]) and their contribution
to muscle regeneration by acting on both myogenic (13) and
fibroadipogenic (48) precursors.
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